CSL surges 16% as Australian companies defy the economic slowdown

CSL’s profit growth and restructuring spark market confidence with stock rising 16% amid ongoing healthcare improvements

‘The market is liking what it’s doing’ regarding CSL’s profit growth and restructuring efforts.

Filip Tortevski from Wealth Within discusses how CSL’s restructuring plan is boosting confidence.

CSL’s stock rose 16% on earnings, indicating market approval of their strategy.

AI and efficiency improvements are key factors in the potential healthcare turnaround.

A sustained positive trend in the U.S. market could benefit Australian companies.

Subscribe to never miss an episode of Ticker – https://www.youtube.com/@weareticker